1 Product identity
Ingredient risk
Contains restricted ingredients
L-Lysine 500 mg
BrandCVS Health→Amino acid/Protein Other (e.g. tea bag) 12 ingredients 1 banned 1 caution DSLD #239495Net contents: 250 Caplet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-11-21
2 Ingredients (12)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
HypromelloseHypromellose—
PolydextrosePolydextrose—
TriglyceridesTriglyceride (unspecified)—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
L-Lysine — Limited Evidence
⚠ GI discomfort at high doses
⚠ May increase calcium absorption
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
Magnesium — Use with Caution
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID239495
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-11-21
6 More from CVS Health
View CVS Health Safety Scorecard → 37 products
AcidophilusB1 100 mgBiotin 5000 mcgCalcium 600 mg & Vitamin D3Calcium 600 mg & Vitamin D3Calcium 600 mg & Vitamin D37 Cite this page
Vancouver
Pkhakadze G. L-Lysine 500 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/l-lysine-500-mg-239495/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG